γδ T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 243-247

  Cela, M E ^a   Holladay, M S ^a   Rooney, C M ^a,b   Richardson, S ^a   Alexander, B ^a   Krance, R A ^a,b   Brenner, M K ^a,b   Heslop, H E ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

BMT; Gamma delta T cells; Regeneration; T cell depleted

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MYCOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFECTION; MALE; MYCOSES; NUCLEAR FAMILY; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030067424     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kernan NA, Bartsch G. Ash RC er al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
2. Henslee-Downey PJ. Choosing an alternative bone marrow donor among available family members. Am J Pediatr Hematol Oncol 1993; 152: 150-161.
3. Casper J, Camitta B, Truitt R et al. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354-2363.
4. Ash RC. Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. New Engl J Med 1990; 322: 485-494.
5. Antin JH, Bierer BE, Smith BR et al. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood 1991; 78: 2139-2149.
6. Keever CA. Small T, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T cell-depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
7. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first two years. Ann Intern Med 1993; 119: 207-214.
8. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
9. Ault KA, Antin JH, Ginsburg D. Phenotype of recovering Iymphoid cell populations after marrow transplantation. J Exp Med 1985; 161: 1483-1502.
10. Janossy G. Prentice HG, Grob J et al. T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol 1986; 63: 577-586.
11. Reittie JE, Gottlieb D. Heslop HE et al. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood 1989; 73: 1351-1358.
12. Rooney CM, Wimperis JZ, Brenner MK et al. Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation. Br J Haematol 1986; 62: 413-420.
13. Janeway CA, Jones B, Hayday A. Specificity and function of T cells bearing gamma delta receptors, Immunol Today 1988; 9: 73-76.
14. Lanier LL, Serafini AT, Ruitenbera JJ et al. The gamrna T cell antigen receptor. J Clin Immunol 1987; 7: 429-440.
15. Ferrick DA, Ohashi PS, Wassace V et al. Thymic ontogeny and selection of alpha beta and gamma delta T cells. Immunol Today 1989; 10: 403-407.
16. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Ann Rev Immunol 1992; 10: 123-151.
17. De Paoli P, Gennari D, Martelli P et al. T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J Infect Dis 1990; 161: 1013-1016.
18. Norton J, AI-Saffar N, Sloane JP. An immunohistological study of gamma delta lymphocytes in human cutaneous graft versus host disease. Bone Marrow Transplant 1991; 7: 205-208.
19. Paloczi K, Poros A. Szelenyi J et al. TCR gamma delta bearing lymphocytes in peripheral blood of allogeneic bone marrow transplant patients. Leukemia 1992; 6: 98S-100S.
20. Van Der Harst D. Brand A, Van Luxemburg-Heijs SA et al. Selective outgrowth of CD45RO+V gamma 9+/V gamma2+ T cell receptor gamma delta T cells early after bone marrow transplantation. Blood 1991; 76: 1875-1881.
21. Biassoni R, Ferrini S, Priglione I et al. Activated CD3-CD16 natural killer cells express a subset of the lymphokine genes that are induced in activated TCR alpha beta and garnma delta T cells, Scand J Immunol 1991; 33: 247-252.
22. Koehler M, Hurwitz CA. Krance RA et al. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors. Bone Marrow Transplant 1994; 13: 571-575.
23. Prentice HG, Blacklock HA, Janossy G et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; i: 472-475.
24. Rooney CM, Loftin SK, Holliday MS et al. Early identification of Epstein-Barr virus-associated post-transplant lymphoproliferative disease. Br J Haematol 1995; 89: 98-103.
25. Prentice HG, Kibbler CC, McWhinney P. Antimicrobial prophylaxis and treatment after chemotherapy or marrow transplantation. In: Hoffbrand AV, Brenner MK (eds). Recent Advances in Haematology. London: Churchill Livingstone, 1992, pp 173-194.
26. Rooney CM, Smith CA, Ng C et al. Use of gene-modified Virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 1995; 345: 9-13.
27. Papadopoulos EB, Ladanyi M. Emanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
28. Vilmer E, Guglieimi P, David V et al. Predominant expression of circulating CD3+ lymphocytes bearing gamma delta T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation. J Clin Invest 1988; 82: 755-761.
29. Viale M, Ferrini S. Bacigalupo A. TCR gamma delta positive lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 249-253.